Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03497767
Title A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases (OUTRUN)
Acronym OUTRUN
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Trans Tasman Radiation Oncology Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Calvary Mater RECRUITING Newcastle New South Wales 2298 Australia Details
Liverpool Hospital RECRUITING Sydney New South Wales 2002 Australia Details
St. Vincents Hospital NOT_YET_RECRUITING Sydney New South Wales 2010 Australia Details
Westmead Hospital RECRUITING Sydney New South Wales 2145 Australia Details
Blacktown Hospital RECRUITING Sydney New South Wales 2148 Australia Details
St George Hospital RECRUITING Sydney New South Wales 2217 Australia Details
Princess Alexandra Hospital RECRUITING Brisbane Queensland 4102 Australia Details
ICON Cancer Centre Greenslopes RECRUITING Brisbane Queensland 4120 Australia Details
Royal Adelaide Hospital NOT_YET_RECRUITING Adelaide South Australia Australia Details
Peter MacCallum Cancer Center RECRUITING Melbourne Victoria 3002 Australia Details
Monash Health RECRUITING Melbourne Victoria 3175 Australia Details
Sir Charles Gairdner NOT_YET_RECRUITING Perth Western Australia Australia Details
National University Hospital RECRUITING Singapore 119074 Singapore Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field